As of 2025-05-21, the EV/EBITDA ratio of Mayne Pharma Group Ltd (MYX.AX) is -8.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MYX.AX's latest enterprise value is 512.65 mil AUD. MYX.AX's TTM EBITDA according to its financial statements is -62.46 mil AUD. Dividing these 2 quantities gives us the above MYX.AX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 8.8x | 7.2x |
| Forward P/E multiples | 4.3x - 4.9x | 4.4x |
| Fair Price | (4.58) - (3.61) | (4.27) |
| Upside | -170.7% - -155.7% | -165.9% |
| Date | EV/EBITDA |
| 2025-05-16 | -8.23 |
| 2025-05-15 | -7.93 |
| 2025-05-14 | -7.48 |
| 2025-05-13 | -8.64 |
| 2025-05-12 | -8.74 |
| 2025-05-09 | -9.05 |
| 2025-05-08 | -9.05 |
| 2025-05-07 | -9.01 |
| 2025-05-06 | -8.78 |
| 2025-05-05 | -8.79 |
| 2025-05-02 | -8.90 |
| 2025-05-01 | -8.90 |
| 2025-04-30 | -8.91 |
| 2025-04-29 | -8.95 |
| 2025-04-28 | -8.88 |
| 2025-04-24 | -8.92 |
| 2025-04-23 | -8.81 |
| 2025-04-22 | -8.95 |
| 2025-04-17 | -8.96 |
| 2025-04-16 | -8.85 |
| 2025-04-15 | -8.91 |
| 2025-04-14 | -8.86 |
| 2025-04-11 | -8.86 |
| 2025-04-10 | -8.86 |
| 2025-04-09 | -8.81 |
| 2025-04-08 | -9.05 |
| 2025-04-07 | -8.85 |
| 2025-04-04 | -9.16 |
| 2025-04-03 | -9.20 |
| 2025-04-02 | -9.20 |
| 2025-04-01 | -9.22 |
| 2025-03-31 | -9.20 |
| 2025-03-28 | -9.21 |
| 2025-03-27 | -9.20 |
| 2025-03-26 | -9.20 |
| 2025-03-25 | -9.22 |
| 2025-03-24 | -9.20 |
| 2025-03-21 | -9.20 |
| 2025-03-20 | -9.18 |
| 2025-03-19 | -9.17 |
| 2025-03-18 | -9.18 |
| 2025-03-17 | -9.16 |
| 2025-03-14 | -9.16 |
| 2025-03-13 | -9.16 |
| 2025-03-12 | -9.18 |
| 2025-03-11 | -9.18 |
| 2025-03-10 | -9.17 |
| 2025-03-07 | -9.18 |
| 2025-03-06 | -9.20 |
| 2025-03-05 | -9.18 |